NCT03663881View on ClinicalTrials.gov

Safety Assessment of P2Et Extract in Healthy Voluntary Subjects in Colombia

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

May 15, 2020

Study Completion Date

May 15, 2020

Conditions
ToxicitySafety Issues
Interventions
DRUG

P2Et extract

P2Et extract daily doses. Dosage scaling will be performed according to the 3 + 3 standard design.

Trial Locations (1)

110221

Hospital Universitario San Ignacio, Bogotá

All Listed Sponsors
collaborator

Pontificia Universidad Javeriana

OTHER

lead

Hospital Universitario San Ignacio

OTHER

NCT03663881 - Safety Assessment of P2Et Extract in Healthy Voluntary Subjects in Colombia | Biotech Hunter | Biotech Hunter